Reactive Oxygen Species-Mediated Mitochondrial-Targeted Therapeutics in Hepatic Disorders: Current Progress and...

Area of Science:

• Mitochondrial biology and pathophysiology
• Hepatology and liver disease research
• Oxidative stress and cellular signaling

Background:

• Mitochondrial dysfunction, driven by reactive oxygen species (ROS), is central to liver diseases such as nonalcoholic fatty liver disease (NAFLD), alcoholic liver disease (ALD), and liver fibrosis.
• Mitochondria are both sources and targets of ROS, highlighting their critical role in liver disease pathogenesis and cellular energy regulation.

Purpose of the Study:

• To review the causes of mitochondrial dysfunction, emphasizing the role of ROS in hepatic disorders.
• To discuss current and emerging therapeutic strategies targeting mitochondrial dysfunction for liver diseases.
• To explore recent advances in mitochondrial-targeted therapeutics and their clinical potential.

Main Methods:

• Literature review of studies on mitochondrial dysfunction, ROS, and hepatic disorders.
• Analysis of current therapeutic approaches including antioxidants, biogenesis enhancers, and nanotechnology.
• Examination of emerging strategies like mitochondrial dynamics modulation and mitophagy.

Main Results:

• Reactive oxygen species (ROS) are significant contributors to mitochondrial dysfunction in various hepatic disorders.
• Mitochondria-specific antioxidants, enhanced mitochondrial biogenesis, and targeted delivery systems are key therapeutic avenues.
• Modulating mitochondrial dynamics and mitophagy presents novel therapeutic potential for restoring cellular homeostasis.

Conclusions:

• Targeting the interplay between ROS and mitochondrial dysfunction is crucial for developing effective therapies for hepatic disorders.
• Translating current and emerging mitochondrial-targeted strategies into clinical applications holds significant promise for managing liver diseases.
• Future research should focus on innovative approaches to exploit mitochondrial pathways for treating liver conditions.